Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers, Advocate Aurora Health, 2801 W. Kinnickinnic River Parkway, Ste. 880, Milwaukee, Wisconsin 53215, USA.
J Interv Cardiol. 2021 Oct 31;2021:9923440. doi: 10.1155/2021/9923440. eCollection 2021.
To describe our institution's experience with the AngioVac system.
Intracardiac and intravascular masses previously required surgical excision, but now, there are a number of minimally invasive options. With the advent of vacuum aspiration, more specifically the AngioVac System (AngioDynamics, NY, USA), there exists a system with both low mortality and minor complications. However, the number of retrospective studies remains limited. Outcome data for high-risk patients are also limited.
Data were collected and analyzed in patients who underwent AngioVac therapy at our tertiary care center from January 2014 to December 2020.
Our results demonstrated a 93.3% intraoperative success rate and a 100% intraoperative survival rate. However, a number of complications, including but not limited to hematomas, anemia, and hypotension, occurred, as described below.
Our experiences demonstrated good outcomes and continue to support the usefulness of the AngioVac System. The data also support the use of AngioVac as a treatment option for the debulking or removal of right heart masses in critically ill patients.
描述我们机构使用 AngioVac 系统的经验。
以前，心脏内和血管内肿块需要手术切除，但现在有许多微创选择。随着真空抽吸的出现，特别是 AngioVac 系统（AngioDynamics，纽约，美国）的出现，出现了一种死亡率低、并发症少的系统。然而，回顾性研究的数量仍然有限。高危患者的预后数据也有限。
我们在 2014 年 1 月至 2020 年 12 月期间在我们的三级医疗中心接受 AngioVac 治疗的患者中收集和分析了数据。
我们的结果显示术中成功率为 93.3%，术中存活率为 100%。然而，发生了许多并发症，包括但不限于血肿、贫血和低血压。
我们的经验表明结果良好，并继续支持 AngioVac 系统的有用性。这些数据还支持将 AngioVac 用作治疗重症患者右心肿块减积或清除的治疗选择。
